Goldman SACHS & Co. LLC, 10% Owner at Panbela Therapeutics, Inc. (PBLA), sold 145,748 shares at $0.71 ($103K) on 2023-11-08, disclosed to the SEC on 2023-11-13.
Open-market sale of $103k PBLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 72,874 | $52K | 50.0% |
| 2 | $0.71 | 72,874 | $52K | 50.0% |
| Total | $0.71 avg | 145,748 | $103K | 100% |
| Filing → |
| NCAC | BUY | 2023-03-08 | $0 | — | Filing → |
| FLYW | SELL | 2022-11-17 | $15.0M | — | Filing → |
| FLYW | SELL | 2022-06-10 | $757K | — | Filing → |